Antitumor effect of double immunization of mice with mucin 1 and its coding DNA

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 3893-3898

  Mushenkova, Natalya ^a   Moiseeva, Ekaterina ^a   Chaadaeva, Alexandra ^a   Den Otter, William ^b   Svirshchevskaya, Elena ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cellular response; DNA immunization; Mouse models of breast cancer; MUC1; Spontaneous tumors

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; MUCIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; BREAST CANCER; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA PROTEIN COMPLEX; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; CA-15-3 ANTIGEN; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; DNA; FEMALE; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 27944492301     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM and Gendler SJ: Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J Immunother 26(1): 47-62, 2003.
2. Pecher G, Haring A, Kaiser L and Thiel E: Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol Immunother 51(11-12): 669-673, 2002.
3. Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L and Livingston PO: Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 6(5): 1693-1701, 2000.
4. Festing MFW: Inbred strains of mice. Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine. World Wide Web 1999. (URL: http://www.informatics.jax. org/external/festing/mouse/docs/CBRB.shtml).
5. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning, A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, NY, pp. 7.6-7.9, 1989.
6. PET System Manual, 10th edition, pp. 42, 48. http://www.takarabio.co.jp/ goods/catalog/pdf/petsys.pdf
7. Vodovozova EL, Moiseeva EV, Grechko GK, Gayenko GP, Nifant'ev NE, Bovin NV and Molotkovsky JG: Antitumour activity of cytotoxic liposomes equipped with selector ligand SiaLe(X), in a mouse mammary adenocarcinoma model. Eur J Cancer 36(7): 942-949, 2000.
8. + T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells. Int J Cancer 109(2): 259-264, 2004.
9. Johnen H, Kulbe H and Pecher G: Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1). Cancer Immunol Immunother 50(7): 356-360, 2001.
10. Blohm U, Roth E, Brommer K, Dumrese T, Rosenthal FM and Pircher H: Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes. J Immunol 169(10): 5522-5530, 2002.